New perspectives in Barrett’s oesophagus by Cauchi, Maurice N.
Most of us have been brought up on the dogma that one important complication of reflux oesophagitis is Barrett’s oesophagus which in turn is the precursor of 
adenocarcinoma of the oesophagus.  It appears that this view 
gives too glum a picture of what is actually happening.
Carcinoma of the oesophagus is not a common cancer in 
Malta. According to data from the Cancer Registry, between 
1998 -2000  there were 27 new cases (21 males, 6 females) with a 
mortality of 29 (22 males, 7 females).
It has always been a worry that chronic reflux leads to 
irritation and inflammation of the lower part of the oesophagus, 
which eventually leads to intestinal metaplastic changes, 
dysplasia and eventually adenocarcinoma. 
These concepts relating to carcinogenesis seem now to be 
in need of a considerable degree of revision, if not complete 
overhaul, following data published recently by Brian J. Reid, 
MD, from the Division of Human Biology and the Division of 
Public Health Sciences at the Fred Hutchinson Cancer Research 
Center in Seattle, Washington1. 
He and his colleagues studied 248 patients involving over 
20,000 person-months of follow-up. They investigated the 
changes in chromosomes in these patients using sophisticated 
computerised technology to assess single nucleotide 
polymorphisms.
As expected, they found several changes in the DNA of 
these patients, including small localised deletions involving 
particularly chromosome 9 (9p), which occurred in either one 
or both of the chromosomes. These changes were found in 69% 
of the patients studied, but remained more or less stable over 
time - involving a follow-up period of up to two decades - and 
therefore were of no prognostic significance from the cancer 
progression point of view.
On the other hand, in about a third of the patients, there were 
more significant changes, sometimes involved gains or losses of 
large chromosomal regions, or even whole chromosomes. These 
involved chromosomes 17, 15 and 13 but not other chromosomes.
Dr Reid believes that these changes tend to occur suddenly, a 
couple of years before cancer becomes manifest. He states “... we 
found that the cells had undergone a genome doubling, such that 
single surviving chromosome 17s were now being replicated. And 
that was occurring right before the development of cancer.”
He concluded that Barrett’s patients could be classified into 
‘progressors’ and ‘non-progressors.’ The majority of patients were 
non-progressors, meaning that they were at no obvious risk of 
developing cancer. 
These findings have considerable implications both in the 
understanding of the process of carcinogenesis, as well in applied 
clinical practice.
It has always been assumed that cancer progression is a linear 
process, often taking decades before clinical manifestations 
become obvious. These findings, on the other hand imply that 
the evolution of cancer is not linear but ‘punctuate’, namely, 
completely different mutations/deletions can take place relatively 
suddenly, producing a specific alteration in the DNA.
From the clinical point of view, Dr Reid believes that this 
behaviour explains why “current strategies grossly fail to detect 
cancer in patients diagnosed with Barrett’s oesophagus.” Dr Reid 
emphasized that less than 1% of patients diagnosed with Barrett’s 
oesophagus develop cancer each year and concludes that doctors 
are scaring patients unnecessarily.  His advice to doctors is this: 
“After you tell a patient that they have Barrett’s and that only a very 
small minority develop cancer, just stop.”
In his opinion, patients should be assessed by techniques 
(such as the ones described in the paper) which can select those 
at high risk, to avoid unnecessary panic and over-investigation of 
those who are at a much lesser risk.  
Chromosome changes, including aneuploidy and polyploidy 
are a common occurrence in cancer cells. What is unique to 
these findings is that specific chromosome abnormalities have 
been detected in tissue well before cancer actually appears. If 
this finding is shown to occur also in more commonly occurring 
tumours (e.g. prostate cancer), then this could become an 
important tool in distinguishing tumours which have an increased 
likelihood of progression.
Selecting patients for special follow-up on the basis of 
changes in their chromosomal make-up would make sense if such 
techniques, as used in this study, were readily available, a project 
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